MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

Meeting: 2019 International Congress

Abstract Number: 1738

Keywords: Cognitive dysfunction, Orthostatic hypotension(OH)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients.

Background: Emerging evidence suggests an association between cognitive impairment and autonomic dysfunction in Parkinson’s disease (PD). However, there is lack of information between the relationship of HRV and changes in cognition in this population.

Method: Nineteen consecutive PD patients without dementia in Hoehn & Yahr stage 2.1±0.2 mean (SD) enrolled in a prospective study of Fear of Falling and falls were assessed by short-term HRV analysis and blood pressure measures during postural changes. EKG were recorded during 5 minutes in resting (RS) and standing (SS) states. Time domain (Mean RR, SDNN, RMSSD), frequency domain (VLF, LF, HF, LF/HF) and non-linear (DFA α1, DFA α2, SampEn) parameters were calculated. Data in RS and SS and its difference (DS) were analyzed. Cognitive performance was evaluated by MoCA, Frontal Assessment battery [FAB], Trail making test [TMT-B], Digit symbol modality test [DSMT], phonemic fluency and Stroop word-color test [SCWT].

Results: Eleven patients (57%) were classified as mild cognitive impairment (PD-MCI) by MoCA. The mean (SD) of age and illness duration were 70.9 ± 6.5 and 8.1 ± 4.7 years respectively. There was no difference in age, gender, illness duration, blood pressure, LED or any MDS-UPDRS scores between groups with or without MCI; MCI-group showed significantly higher LF/HF-SS ratio (p=0.032), lower RMSSD-DS (p=0.003) and lower SampEn-DS (p=0.032) than non-MCI group. The poorer performance in multiple cognitive domain tests was significantly associated with HRV indexes: the phonemic fluency scores with reduced overall HRV (RMSSD-SS p=0.016; SDNN-RS p=0.039; SDNN-SS p=0.016); decreased baroreflex function (LF-SS p=0.029; HF-RS p=0.017; HF-SS p=0.037) and SampEn-SS p=0.049); MoCA test was associated to lower RMSSD-DS (p=0.003) and higher DFA α2-SS (p=0.044); SWCT was associated to higher values of DFA α2-SS (p=0.026) and DFA α2-DS (p=0.024). No significant differences were found between groups with or without MCI or any independent cognitive test and blood pressure measures during postural changes.

Conclusion: Reduced HRV reflecting decreased parasympathetic activity independently of orthostatic hypotension is significantly associated with PD-MCI. Considering the high rate of conversion of PD-MCI to PDD its role as predictive biomarker should be explored in future studies.

To cite this abstract in AMA style:

C. Terroba-Chambi, D. Vigo, M. Merello. Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/heart-rate-variability-and-cognitive-impairment-in-parkinsons-disease/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/heart-rate-variability-and-cognitive-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley